Seeking Alpha

vinyal

vinyal
Send Message
View as an RSS Feed
View vinyal's Comments BY TICKER:
Latest  |  Highest rated
  • Financial Engineering, Not Fundamentals, Is Driving Markets [View article]
    great article. yes the market might go higher but is it worth the risk vs. the reward.
    Aug 11, 2015. 12:34 PM | 3 Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    BIOTECH sector has topped out. The institutional money is running away. IF you want to get trampled by a herd of elephants go ahead and look at it as a buying opportunity
    Dec 23, 2014. 01:54 PM | Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    GILD is already the red headed step child of the congress. Good luck with lobbying for a company that is looked upon as a vulture..
    Dec 23, 2014. 01:50 PM | Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    and a 25% drop today
    Dec 23, 2014. 01:40 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    Too complicated for folks to understand that. Catching falling knives sounds more logical and sound
    Dec 23, 2014. 01:25 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    He already adviced you to catch it yesterday.
    Dec 23, 2014. 01:23 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    It would be sound advice to say i was wrong and let people move to the sidelines. The biotech sector has hit a road bump and there is no point in standing in front of a freight train and beating your chest and say that I am right.
    Dec 23, 2014. 01:22 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    I have nothing against the author. His biggest problem is his lack of flexibility. When GILD fell yesterday it was a warning sign. The advice should have been move to the sidelines and let things settle down. Instead he adviced catching falling knives. This reminds me of his other advice on the small cap oil where his recommendations to keep buying them cost people 80-100 % drop in his recommendation. He is doing the exact same with GILD. This is a sure shot way of ending in the poor house. Bad advice is all i can say
    Dec 23, 2014. 01:20 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    They have the FDA backing so good luck lawyers
    Dec 23, 2014. 01:13 PM | Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    Have to disagree with your analysis that fundamentals have not changed. This is a game changer and something biotechs companies have to watch for I.E. competition
    Dec 22, 2014. 12:15 PM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    yep financial engineering is the name of the game for them now
    Dec 22, 2014. 12:13 PM | Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    Walk away. This is a second big wound on GILD in the last couple of months. It is a badly wounded stock and lot of people will get rid of this dog sooner or later.
    Dec 22, 2014. 11:45 AM | Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    I call it common sense. Listen to Mr Market
    Dec 22, 2014. 11:44 AM | 1 Like Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    The problem with the author is he does not change his stance when things change and keeps supporting his thesis while the market is saying different. Lack of flexibility is the reason why his picks are blowing up in your face time after time. The ABBVIE and ESRX is a game changer for GILD. Trust me it is good for all health care consumers. I am a doc and i cannot tell you enough how these companies are exploiting the masses on the notion that "so much money has gone into R&D" But every family that has cancer that i take care of go bankrupt because of such practices. Just a sad situation
    Dec 22, 2014. 11:43 AM | 3 Likes Like |Link to Comment
  • Gilead: What's Ahead In 2015 For This Biotech Juggernaut [View article]
    ESRX way to go!! i like this move
    Dec 22, 2014. 11:14 AM | Likes Like |Link to Comment
COMMENTS STATS
123 Comments
165 Likes